These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 110964)

  • 1. [Treatment of Pseudomonas aeruginosa pneumonia with amikacin (author's transl)].
    Izawa T; Katakura K
    Jpn J Antibiot; 1979 Apr; 32(4):532-4. PubMed ID: 110964
    [No Abstract]   [Full Text] [Related]  

  • 2. [Amikacin treatment of septicemia due to gentamicin-resistant gram-negative bacilli (author's transl)].
    Tomioka H; Kobayashi Y; Tamatani S; Morishita T; Hasegawa Y
    Jpn J Antibiot; 1975 Jun; 28(3):305-8. PubMed ID: 807757
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparison of bactericidal effects of four aminoglycoside antibiotics: amikacin, gentamicin, kanamycin and tobramycin (author's transl)].
    Drugeon HB; Courtieu AL
    Ann Microbiol (Paris); 1979 Apr; 130A(3):331-43. PubMed ID: 114083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gentamicin-resistant bacillary infection. Clinical features and amikacin therapy.
    Leonard JM; McGee ZA; Alford RH
    Arch Intern Med; 1978 Feb; 138(2):201-5. PubMed ID: 415674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibacterial activity of gentamicin, tobramycin, amikacin, and sisomicin in vitro (author's transl)].
    Skalova R; Hajsig D; Babić I; Mostovac D
    Lijec Vjesn; 1978 Nov; 100(11):708-10. PubMed ID: 107386
    [No Abstract]   [Full Text] [Related]  

  • 6. Activity of amikacin, gentamicin and kanamycin against Pseudomonas aeruginosa.
    Ximenes J; Bassoi ON; de Menezes JP; Fry W
    J Int Med Res; 1976; 4(3):165-75. PubMed ID: 829072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amikacin and netilmicin resistance in Pseudomonas aeruginosa: incidence and transfer.
    Knothe H; Krcméry V
    Chemotherapy; 1979; 25(1):23-9. PubMed ID: 105839
    [No Abstract]   [Full Text] [Related]  

  • 8. Gentamicin and amikacin disk susceptibility tests with Pseudomonas aeruginosa: definition of minimal inhibitory concentration correlates for susceptible and resistant categories.
    Barry AL; Thornsberry C; Jones RN
    J Clin Microbiol; 1981 May; 13(5):1000-3. PubMed ID: 6787072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fundamental and clinical studies on amikacin (BB-K8) in complicated urinary tract infections (author's transl)].
    Mita T; Mayumi K; Kataoka N; Ishigami J
    Jpn J Antibiot; 1977 Mar; 30(3):215-22. PubMed ID: 404447
    [No Abstract]   [Full Text] [Related]  

  • 10. [Laboratory and clinical investigation of amikacin (BB-K8) (author's transl)].
    Kato Y; Saito A; Ishikawa K; Nakayama I; Tomizawa M
    Jpn J Antibiot; 1974 Jun; 27(3):343-7. PubMed ID: 4215898
    [No Abstract]   [Full Text] [Related]  

  • 11. Amikacin + ceftazidime therapy of experimental right-sided Pseudomonas aeruginosa endocarditis in rabbits.
    Bayer AS; Lam K; Norman D; Kim KS; Morrison JO
    Chemotherapy; 1985; 31(5):351-61. PubMed ID: 3931992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined effect of cefotaxime and aminoglycoside antibiotics on Pseudomonas strains and group D streptococci].
    Linda H; Patzer J
    Med Dosw Mikrobiol; 1984; 36(4):223-9. PubMed ID: 6100122
    [No Abstract]   [Full Text] [Related]  

  • 13. Bactericidal activity of amikacin and gentamicin.
    Shah RM; Heetderks G; Stille W
    Chemotherapy; 1977; 23(4):260-6. PubMed ID: 405182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amikacin resistance developing in patients with Pseudomonas aeruginosa bronchopneumonia.
    Amirak ID; Williams RJ; Noone P; Wills MR
    Lancet; 1977 Mar; 1(8010):537-8. PubMed ID: 65626
    [No Abstract]   [Full Text] [Related]  

  • 15. [Laboratory and clinical evaluation of amikacin (BB-K8) (author's transl)].
    Gonda N; Shimada S; Fujimori I; Katsu M; Miyazaki R
    Jpn J Antibiot; 1974 Oct; 27(5):620-4. PubMed ID: 4617008
    [No Abstract]   [Full Text] [Related]  

  • 16. [Susceptibility of Pseudomonas aeruginosa recently isolated from clinical specimens to various antimicrobial agents and changes of susceptibility to carbenicillin, gentamicin and amikacin (author's transl)].
    Kosakai N; Oguri T
    Jpn J Antibiot; 1980 Jun; 33(6):668-74. PubMed ID: 6779031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A long-term study of gentamicin-resistant Pseudomonas aeruginosa in a general hospital.
    Duncan IB; Rennie RP; Duncan NH
    J Antimicrob Chemother; 1981 Feb; 7(2):147-55. PubMed ID: 6783608
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical experience with amikacin (BB-K8) (author's transl)].
    Nakagawa K; Watanabe K; Kabe J; Suzuki T; Koyama S
    Jpn J Antibiot; 1974 Jun; 27(3):337-42. PubMed ID: 4215897
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful treatment of multiresistant pseudomonas peritonitis with combination of azlocillin and amikacin.
    Leung AC; Gribben J; Sleigh JD; Boulton Jones JM
    Scott Med J; 1983 Jan; 28(1):69-70. PubMed ID: 6403983
    [No Abstract]   [Full Text] [Related]  

  • 20. Susceptibility of current clinical isolates of Pseudomonas aeruginosa and enteric gram-negative bacilli to amikacin and other aminoglycoside antibiotics.
    Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC
    J Infect Dis; 1976 Nov; 134 SUPPL():S394-90. PubMed ID: 825591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.